A “Pan” group III mGluR PAM for Parkinson’s disease

Scroll To Explore

DT095435: A novel “pan” group III metabotropic glutamate receptor positive allosteric modulator for Parkinson’s disease

This poster presents the profiling of DT095435 development candidate as a potential novel anti-dyskinetic treatment for Parkinson’s disease.